JUL 19, 2018 10:00 AM PDT

Medical Marijuana Approved to Replace Opioid Prescriptions in New York State

New York State expanded their medical marijuana program in November of 2016.  Since that time the leaders of the State and Health Departments have been working to add qualifying conditions and expand the program further.  Between November of 2016 and today’s date, their medical marijuana program has added a multitude of illnesses or ailments including generalized chronic pain, post-traumatic stress disorder (PTSD), and now, as of this month, opioid use. 

On July 12, 2018, the NY State Department of Health announced that medical marijuana is approved for use as a replacement for opioid prescriptions by registered medical professionals approved within the Medical Marijuana Program. 

New York state, like many states across the country, is being dramatically affected by the costs of the acknowledged opioid epidemic in the United States.  New York is working diligently, in a coordinated effort, to fight addition, reduce opioid related deaths, and fully utilize existing state programs aimed at helping individuals affected by this issue.  The situation has become so dire that in the news brief released by the State, the policies regarding opioid replacement with medical marijuana (within the scope of the state’s Medical Marijuana Program), were considered emergency regulations effective immediately. 

The specific regulations indicate that any condition for which an opioid could be prescribed will be considered a qualifying condition for medical marijuana.  Providers can certify patients to use medical marijuana in place of opioids and temporary ID cards will be available to purchase products in a more streamlined manner.

In addition, this same expansion added that opioid use would also be considered a qualifying condition in order to switch someone from opioids to medical marijuana.  To further the efforts for reducing the burden of the opioid epidemic and create a more accessible medical marijuana program for all, the State has also recently enhanced the Program by permitting home delivery of products and empowering other front-line care providers beyond the MD role, namely Nurse Practitioners and Physician Assistants, the ability to certify patients.

The final permanent regulations on this issue will be adopted on August 1, 2018 after the state has a public comment period between the time these changes were proposed in June and their pilot adoption in July.  According to the NY State Department of Health, there are 62,000 plus certified patients and more than 1700 practitioners participating in the medical marijuana program. 

Sources: NY Department of Health, NY Opioid Epidemic, NY State Medical Marijuana Program,

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAR 28, 2018
Cannabis Sciences
MAR 28, 2018
Medicinal Cannabis: Commonly Used Terms Part II
Part two in the series focused on commonly used terms related to medical cannabis. Areas discussed include cannabis botany, synthetics, extracts, concentrates, and pharmaceuticals....
MAY 06, 2018
Cannabis Sciences
MAY 06, 2018
Cannabis and the Relief for HIV/AIDS
On Saturday May 5, 2018 Buffalo, NY celebrated their 26th annual AIDS walk that brings awareness and honor to those who have lost the fight, and to those w...
JUN 21, 2018
Cannabis Sciences
JUN 21, 2018
From Gateway Drug to Exitway Drug: How Cannabis is Saving America from the Opioid Epidemic
For years researchers, journalists, and anti-drug organizations have touted that cannabis is the gateway drug to harder narcotics. A study conducted by res...
JUL 06, 2018
Cannabis Sciences
JUL 06, 2018
How the Biphasic Effect of Cannabinoids Controls Dosing
Cannabis compounds have biphasic properties, which means that low and high doses of the same substance can produce opposite effects. Small doses of cannabi...
JUL 26, 2018
Cannabis Sciences
JUL 26, 2018
Cannabinoids for Dementia
Researchers are looking at exploring cannabinoids like THC and CBD for treatment of dementia, either specifically for pathogenesis of disease or for symptoms associated with dementia....
AUG 07, 2018
Cannabis Sciences
AUG 07, 2018
Keeping Up with Lab Testing for Synthetic Cannabinoids
Synthetic cannabinoid substance make-up is evolving and changing more rapidly than diagnostic testing can detect. One group of researchers in Australia have validated testing for 19 syntheti...
Loading Comments...